Education

Undergraduate
Bilkent University (2005), Genetics
Graduate School
UT Southwestern Medical Center (2010), Cancer Biology

Research Interest

  • Immunotherapy
  • Lung cancer development
  • Metabolic regulation of host anti-tumor immune responses
  • Tumor microenvironment

Publications

Featured Publications LegendFeatured Publications

Pulsatile MEK Inhibition Improves Anti-tumor Immunity and T Cell Function in Murine Kras Mutant Lung Cancer.
Choi H, Deng J, Li S, Silk T, Dong L, Brea EJ, Houghton S, Redmond D, Zhong H, Boiarsky J, Akbay EA, Smith PD, Merghoub T, Wong KK, Wolchok JD, Cell Rep 2019 Apr 27 3 806-819.e5
Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients.
Osa A, Uenami T, Koyama S, Fujimoto K, Okuzaki D, Takimoto T, Hirata H, Yano Y, Yokota S, Kinehara Y, Naito Y, Otsuka T, Kanazu M, Kuroyama M, Hamaguchi M, Koba T, Futami Y, Ishijima M, Suga Y, Akazawa Y, Machiyama H, Iwahori K, Takamatsu H, Nagatomo I, Takeda Y, Kida H, Akbay EA, Hammerman PS, Wong KK, Dranoff G, Mori M, Kijima T, Kumanogoh A JCI Insight 2018 Oct 3 19

Professional Associations/Affiliations

  • Society of Immunotherapy of Cancer (SITC) (2018)
  • American Association for Cancer Research (AACR)
  • International Association of the Study of Lung Cancer (IASLC)